You are here

Inceptor Bio

Inceptor Bio doses first subject in trial of IB-T101 for renal cell carcinoma

Clinical Trials Arena

Wed, 02/26/25 - 11:11 am

clinical trials

renal cell carcinoma

Inceptor, Avectas are latest biotechs to take up solid tumor CAR-T challenge

Fierce Biotech

Wed, 10/12/22 - 11:44 pm

Inceptor Bio generates $37m in funding round as it advances CAR-T platform into the clinic

Biopharma Reporter

Wed, 05/25/22 - 10:13 am

Inceptor Bio raises $37m from Series A to advance CAR-T lead program

Pharmaceutical Business Review

Fri, 05/20/22 - 10:32 am

Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers

BioSpace

Thu, 05/19/22 - 10:52 am